WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'072  2'068  2'062  2'054  2'044  1'990  2'004  1'832 
Births 21  21  21  21  21  18  22  29 
Surviving infants 21  21  21  21  21  18  22  29 
Pop. less than 5 years 107  108  108  104  101  91  125  146 
Pop. less than 15 years 296  295  292  288  286  316  418  425 
Female 15-49 years 467  471  476  481  485  516  511  460 

Number of reported case

(Click for retrospective incidence data for Slovenia)
Diphtheria
Japanese encephalitis
Measles 22 
Mumps 27 
Pertussis 169  178  284  610  442 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Slovenia)
Vaccine year result method % card seen                                                
BCG          98 
DTP1          96 
DTP3          95  96  96  96  96  91 
HepB_BD         
HepB3          90  92  92  97 
Hib3          95  96  96  96  96 
JapEnc         
MCV          94  95  96  95  95  95 
MCV2          95  96  96  96  98 
PCV1         
PCV3         
Pol3          95  96  96  96  96  93 
Rota1         
Rota_last         
Rubella1          94  95  96  95  95 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Slovenia)
BCG 98 
DTP1 98  98  98  98  98  96 
DTP3 95  96  96  96  96  91 
HepB3
HepB_BD
Hib3 95  96  96  96  96 
MCV 94  95  96  95  95  95 
MCV2 95  96  96  96  98  98 
PCV3
Pol3 95  96  96  96  96  93 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes risk groups
DTaPHibIPV 3, 4.5, 6, 18 months; Yes
HepA Yes In case of epidemiological indications
HepAHepB Yes travel
HepB 5 (x2), 6 years; Yes and HCW
HIB Yes Risk group
HPV 11 (x2), 12 years; Yes
Influenza > 65 years; Yes and people with chronic diseases
IPV Yes Travel
MenACWY Yes risk groups
MenC_conj Yes risk groups
MMR 18 months; 5 years; Yes
Pneumo_conj Yes risk groups
Pneumo_ps Yes risk groups
Td Yes In case of injuries
Tdap 8 years; Yes
TT 16 years; Yes
Varicella Yes Risk group

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number YEARLY PLAN  YEARLY PLAN  YEARLY PLAN  2'010  YEARLY PLAN  2'008  YEARLY PLAN 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 78  78  100  100  100  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 70  70  70    70  70  60 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.